Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
raleigh-durham blog main
5
×
san francisco blog main
boston blog main
boston top stories
national top stories
raleigh-durham top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
bristol-myers squibb
celgene
fda
intercept pharmaceuticals
medical device
2019
4d molecular therapeutics
abbvie
acne
activism
What
disease
5
×
drug
5
×
bio
liver
race
roundup
therapy
adds
advanced
alliance
alnylam’s
alzheimer's
approval
approved
areas
bad
bff
biosciences
bio’s
brain
brii
building
cancer
case
companies
conference
deal
deals
developer
devoted
digital
doses
earlier
easl
epidemic
established
failed
fatty
fda
fight
Language
Current search:
drug
×
disease
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed